The local subsidiary of German firm Glenwood GmbH has opened a facility in Taguig City to help pharmaceutical companies ensure drug safety, manage risks and comply with global standards.

The Drug Safety Research Unit (DSRU) has announced the appointment of Linda Härmark as its new director.

Whilst job applications have evolved over the years to bring you new ways of showcasing your skills and experiences, what’s ...

AN 18-year-old in India has made history by securing the Guinness world record for the hairiest male face. Lalit Patidar has ...

Regulatory Shifts and Data-Sharing Advancements Fuel Global Pharmacovigilance Growth, Opening Doors for Seamless Compliance ...

The US pharmacovigilance market is expanding due to rising chronic diseases, stringent FDA regulations, and AI-driven ...

Glenwood Services Philippines Inc. (GSPI) registered with the Board of Investments (BOI) to launch the first pharmaceutical ...

Researchers from the Drug Safety Research Unit are calling for the robust monitoring of the safety of lecanemab, a promising new drug to treat Alzheimer’s Disease (AD). In a review article, published ...

We reduced our fair value estimate to $15.50 per share from $27.20 to account for greater headwinds as a newly stand-alone company since its spinoff from Labcorp in 2023, which will weigh on revenue ...

The 10th GCC Regulatory Affairs Pharma Summit in Dubai concluded successfully, gathering over 650 professionals to discuss ...